Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-21

Clinical Trial Update: A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

View source ↗

Summary

Allergan-sponsored clinical trial of Simbrinza for open-angle glaucoma or ocular hypertension has completed. The provided snippet does not include trial results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Allergan | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Status: COMPLETED